Cost analysis and clinical applicability of the Resonance<sup>®</sup>metallic ureteral stent

Polcari, Anthony J.; Hugen, Cory M.; López-Huertas, Héctor; Türk, Thomas

doi:10.1586/erp.09.74

Cited by 14 publications

(13 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has also been observed that stent replacement is not necessary in most MUO cases, as we also observed herein. In light of the above-described findings, it is apparent that the frequent replacement of a stent can be avoided, thereby improving patients’ quality of life and reducing medical costs [8, 32].…”

Section: Discussionmentioning

confidence: 99%

The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

et al. 2019

View full text Add to dashboard Cite

BackgroundTo study the outcomes and experiences of using metallic stents in treating patients with malignant ureteral obstruction (MUO), we examined the effects of metallic ureteral stenting using the Cook Resonance® stent in the treatment of MUO.MethodsAll patients who had a Resonance metallic stent inserted between April 2015 and March 2018 at one of multiple facilities were prospectively observed with a 1-year follow-up. The primary outcome was the patency rate of the metallic ureteral stent. The secondary outcomes included the complications (e.g., infection and fever).ResultsAlthough stent insertion was attempted in 50 patients, the stent could not be inserted as a ureteral stent in three patients due to severe ureteral stricture, and one ureteral cancer patient was excluded from the analysis. The remaining 46 patients’ median age was 67 years (range 28–85 years) (16 males, 30 females). Twenty-four patients died during the study; their median survival time was 226 days. The median follow-up period for the censored patients was 355 days (range 16–372 days), and just seven patients were still alive without Resonance failure > 1 year later. The women’s IPSS scores tended to be lower than those of the men. Regarding the OABSS score, although the women’s total score tended to be low, the difference between the men’s and women’s scores was nonsignificant. The bacteria detected from urine culture after stent insertion were more gram-positive than gram-negative.ConclusionMetallic ureteric stenting using the Resonance stent is safe and effective for treating MUO. Subjective symptoms were relatively less in the female patients.

show abstract

Section: Discussionmentioning

confidence: 99%

The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The advantage of the Resonance stent is mainly based on its long-term durability. Frequent replacement of the stent could be avoided, thereby improving patient quality of life and reducing medical costs [ 17 , 22 ]. Overall, stent-related symptoms were similar in both kinds of stents in our study, probably resulting from the super-elastic design of the Resonance stent.…”

Section: Discussionmentioning

confidence: 99%

Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents

et al. 2015

View full text Add to dashboard Cite

BackgroundUreteral obstruction caused by extrinsic compression is often associated with intra-abdominal cancers. Internal drainage with ureteral stents is typically the first-line therapy to relieve such obstructions. Novel designs of ureteral stents made of different materials have been invented to achieve better drainage. In this study, we described the functional outcomes of a Resonance metallic ureteral stent (Cook Medical, Bloomington, Indiana, USA) in patients with malignant ureteral obstruction and compare the functional duration of Resonance stents with regular polymeric stents in the same cohort.MethodsCancer patients who received polymeric stents and subsequent Resonance stents for ureteral obstruction between July 2009 and November 2012 were included in a chart review. Stent failure was detected by clinical symptoms, imaging studies, and renal function tests. The functional durations of each stent were calculated, and possible factors affecting stent patency were investigated.ResultsA total of 50 stents were successfully inserted into 50 ureteral units in 42 patients with malignant ureteral obstruction. There were 7 antegrade stents and 43 retrograde stents. There were no major complications. Stent-related symptoms were similar in both kinds of stents. After polymeric stents were replaced with Resonance metallic stents, hydronephrosis subsided or remained stable in 90% (45/50) of the ureteral units. Serum creatinine decreased or remained stable in 90% (38/42) of these patients. The Resonance stent exhibited a mean increase in functional duration of 4 months compared with the polymeric stents (p<0.0001), and 50% (25/50) of the Resonance stents exhibited a significant increase in functional duration (more than 3 months). Pre-operative serum creatinine < 2 was associated with a substantial increase in stent duration.ConclusionsResonance stents are effective and safe in relieving malignant ureteral obstructions after polymeric stents failure. Resonance stents can provide a longer functional duration than polymeric stents and should be offered as an option for internal drainage.

show abstract

“…Furthermore, increased time between stent exchanges has also been shown to provide a significant cost benefit. 14,15 Conclusion Both the Passage and Snake stent designs offer a lower tensile strength and high resistance to extrinsic radial compression compared with previously tested Cook Resonance and Applied Medical Silhouette stents and may offer more efficacious management for extrinsic-etiology ureteral obstruction.…”

Section: Discussionmentioning

confidence: 96%

New Metallic Ureteral Stents: Improved Tensile Strength and Resistance to Extrinsic Compression

Hendlin

Korman²,

Monga³

2012

Journal of Endourology

View full text Add to dashboard Cite

show abstract

Cost analysis and clinical applicability of the Resonance^®metallic ureteral stent

Cited by 14 publications

References 14 publications

The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents

New Metallic Ureteral Stents: Improved Tensile Strength and Resistance to Extrinsic Compression

Contact Info

Product

Resources

About

Cost analysis and clinical applicability of the Resonance®metallic ureteral stent

Cited by 14 publications

References 14 publications

The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study

Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents

New Metallic Ureteral Stents: Improved Tensile Strength and Resistance to Extrinsic Compression

Contact Info

Product

Resources

About

Cost analysis and clinical applicability of the Resonance^®metallic ureteral stent